Document is current
Any future updates will be listed below
-
Authors
,
Lambe, Tosin
Frew, Emma https://orcid.org/0000-0002-5462-1158
Ives, Natalie J.
Woolley, Rebecca L.
Cummins, Carole
Brettell, Elizabeth A.
Barsoum, Emma N.
Webb, Nicholas J. A.
-
Funding
Funding for this research was provided by:
Health Technology Assessment Programme (HTA 08/53/31)
- License Information
-
More Information
Article History
First Online: 20 December 2017
Compliance with Ethical Standards
:
: The study was approved by the North West–GM Central Research Ethics Committee (reference: 12/NW/0766).
: The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), NIHR or the Department of Health.
: NJAW has served on Advisory Boards within the past 5 years for Abbvie, Alexion, AMAG, Astellas, Raptor, Takeda and UCB. These have been related to the design and conduct of early-phase trials in childhood kidney disease. None has been related to the treatment of corticosteroid-sensitive nephrotic syndrome. TL, EF, NJI, RLW, EAB, ENB, and CC declare no conflict of interest.
: Written informed consent was obtained from parents/guardians of participants and written assent was obtained from participants of appropriate age.
